
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The pharmaceuticalisation of ‘healthy’ ageing: Testosterone enhancement for longevity
Matthew Dunn, Kyle Mulrooney, Cynthia Forlini, et al.
International Journal of Drug Policy (2021) Vol. 95, pp. 103159-103159
Closed Access | Times Cited: 29
Matthew Dunn, Kyle Mulrooney, Cynthia Forlini, et al.
International Journal of Drug Policy (2021) Vol. 95, pp. 103159-103159
Closed Access | Times Cited: 29
Showing 1-25 of 29 citing articles:
“They sent it away for testing and it was all bunk”: Exploring perspectives on drug checking among steroid consumers in Queensland, Australia
Timothy Piatkowski, Cheneal Puljević, Cameron Francis, et al.
International Journal of Drug Policy (2023) Vol. 119, pp. 104139-104139
Open Access | Times Cited: 33
Timothy Piatkowski, Cheneal Puljević, Cameron Francis, et al.
International Journal of Drug Policy (2023) Vol. 119, pp. 104139-104139
Open Access | Times Cited: 33
Beyond the law: Exploring the impact of criminalising anabolic–androgenic steroid use on help-seeking and health outcomes in Australia
Timothy Piatkowski, Nick Gibbs, Matthew Dunn
Journal of Criminology (2023) Vol. 57, Iss. 1, pp. 62-82
Open Access | Times Cited: 32
Timothy Piatkowski, Nick Gibbs, Matthew Dunn
Journal of Criminology (2023) Vol. 57, Iss. 1, pp. 62-82
Open Access | Times Cited: 32
“I would never go to the doctor and speak about steroids”: Anabolic androgenic steroids, stigma and harm
Luke Cox, Timothy Piatkowski, Jim McVeigh
Drugs Education Prevention and Policy (2024), pp. 1-13
Open Access | Times Cited: 17
Luke Cox, Timothy Piatkowski, Jim McVeigh
Drugs Education Prevention and Policy (2024), pp. 1-13
Open Access | Times Cited: 17
‘The general concept is a safer use approach’: how image and performance enhancing drug coaches negotiate safety through community care
Timothy Piatkowski, Luke Cox, Nick Gibbs, et al.
Drugs Education Prevention and Policy (2024), pp. 1-9
Closed Access | Times Cited: 14
Timothy Piatkowski, Luke Cox, Nick Gibbs, et al.
Drugs Education Prevention and Policy (2024), pp. 1-9
Closed Access | Times Cited: 14
The Liver King Lie: Misrepresentation, justification, and public health implications
Nick Gibbs, Timothy Piatkowski
International Journal of Drug Policy (2023) Vol. 114, pp. 103979-103979
Open Access | Times Cited: 23
Nick Gibbs, Timothy Piatkowski
International Journal of Drug Policy (2023) Vol. 114, pp. 103979-103979
Open Access | Times Cited: 23
Click, click, buy: The market for novel synthetic peptide hormones on mainstream e-commerce platforms in the UK
Dr Luke Turnock, Nick Gibbs
Performance Enhancement & Health (2023) Vol. 11, Iss. 2, pp. 100251-100251
Open Access | Times Cited: 20
Dr Luke Turnock, Nick Gibbs
Performance Enhancement & Health (2023) Vol. 11, Iss. 2, pp. 100251-100251
Open Access | Times Cited: 20
#Sponseredathlete: the marketing of image and performance enhancing drugs on Facebook and Instagram
Nick Gibbs
Trends in Organized Crime (2023)
Open Access | Times Cited: 20
Nick Gibbs
Trends in Organized Crime (2023)
Open Access | Times Cited: 20
Big business: The private sector market for image and performance enhancing drug harm reduction in the UK
Luke A. Turnock, Nick Gibbs, Luke Cox, et al.
International Journal of Drug Policy (2023) Vol. 122, pp. 104254-104254
Open Access | Times Cited: 19
Luke A. Turnock, Nick Gibbs, Luke Cox, et al.
International Journal of Drug Policy (2023) Vol. 122, pp. 104254-104254
Open Access | Times Cited: 19
Across the spectrum of legality: The market activities of influencers specialized in steroids and other performance and image enhancing drugs
Letizia Paoli, Luke Cox
International Journal of Drug Policy (2023) Vol. 123, pp. 104246-104246
Open Access | Times Cited: 15
Letizia Paoli, Luke Cox
International Journal of Drug Policy (2023) Vol. 123, pp. 104246-104246
Open Access | Times Cited: 15
Influence of edentulism on the structure and function of temporomandibular joint
Huiyun Zheng, Lei Shi, Hongye Lu, et al.
Heliyon (2023) Vol. 9, Iss. 10, pp. e20307-e20307
Open Access | Times Cited: 14
Huiyun Zheng, Lei Shi, Hongye Lu, et al.
Heliyon (2023) Vol. 9, Iss. 10, pp. e20307-e20307
Open Access | Times Cited: 14
Could testosterone be the new methadone? New ways for approaching anabolic-androgenic steroid dependence
Timothy Piatkowski, Ingrid Amalia Havnes, Emma Kill, et al.
Performance Enhancement & Health (2024) Vol. 12, Iss. 1, pp. 100275-100275
Closed Access | Times Cited: 5
Timothy Piatkowski, Ingrid Amalia Havnes, Emma Kill, et al.
Performance Enhancement & Health (2024) Vol. 12, Iss. 1, pp. 100275-100275
Closed Access | Times Cited: 5
Exploring the Impacts of Rurality on Service Access and Harm Among Image and Performance Enhancing Drug (IPED) Users in a Remote English Region
Luke A. Turnock, Kyle Mulrooney
Contemporary Drug Problems (2023) Vol. 50, Iss. 2, pp. 232-253
Open Access | Times Cited: 12
Luke A. Turnock, Kyle Mulrooney
Contemporary Drug Problems (2023) Vol. 50, Iss. 2, pp. 232-253
Open Access | Times Cited: 12
Community pharmacy’s role in dispensing androgens and supporting harm reduction amid current policy dilemmas
Timothy Piatkowski, Lkhagvadulam Ayurzana, Michelle A. King, et al.
Substance Abuse Treatment Prevention and Policy (2025) Vol. 20, Iss. 1
Open Access
Timothy Piatkowski, Lkhagvadulam Ayurzana, Michelle A. King, et al.
Substance Abuse Treatment Prevention and Policy (2025) Vol. 20, Iss. 1
Open Access
The Enhanced Games: Prohibition, harm reduction & the future of sport
Luke A. Turnock
Performance Enhancement & Health (2024) Vol. 12, Iss. 4, pp. 100295-100295
Open Access | Times Cited: 3
Luke A. Turnock
Performance Enhancement & Health (2024) Vol. 12, Iss. 4, pp. 100295-100295
Open Access | Times Cited: 3
Semaglutide, Testosterone and Sildenafil advertising on social media: The Normalisation of lifestyle enhancement drugs
Mikey Hirst, Luke A. Turnock
Performance Enhancement & Health (2024), pp. 100303-100303
Open Access | Times Cited: 3
Mikey Hirst, Luke A. Turnock
Performance Enhancement & Health (2024), pp. 100303-100303
Open Access | Times Cited: 3
Novel wellbeing and repair peptide use in the UK: Netnographic findings
Luke A. Turnock, Evelyn Hearne
Performance Enhancement & Health (2024), pp. 100293-100293
Open Access | Times Cited: 2
Luke A. Turnock, Evelyn Hearne
Performance Enhancement & Health (2024), pp. 100293-100293
Open Access | Times Cited: 2
Who Veridicts Health? Health Professional Discourses on Performance and Image-Enhancing Drugs (PIEDs), Health, and Masculinity
Gemma Nourse, David Moore, Suzanne Fraser
Contemporary Drug Problems (2024) Vol. 51, Iss. 4, pp. 247-263
Open Access | Times Cited: 2
Gemma Nourse, David Moore, Suzanne Fraser
Contemporary Drug Problems (2024) Vol. 51, Iss. 4, pp. 247-263
Open Access | Times Cited: 2
Exploring user narratives of self-medicated black market IPED use for therapeutic & wellbeing purposes
Luke A. Turnock
Performance Enhancement & Health (2021) Vol. 10, Iss. 2, pp. 100207-100207
Closed Access | Times Cited: 13
Luke A. Turnock
Performance Enhancement & Health (2021) Vol. 10, Iss. 2, pp. 100207-100207
Closed Access | Times Cited: 13
Testosterone vs. steroids: Comparing the disciplined bodywork projects of performance and image enhancing drug users in Australia
Edwina James, L. L. Wynn
International Journal of Drug Policy (2022) Vol. 107, pp. 103776-103776
Closed Access | Times Cited: 9
Edwina James, L. L. Wynn
International Journal of Drug Policy (2022) Vol. 107, pp. 103776-103776
Closed Access | Times Cited: 9
Human enhancement drugs: Emerging issues and responses
Vivian Hope, Mair Underwood, Kyle Mulrooney, et al.
International Journal of Drug Policy (2021) Vol. 95, pp. 103459-103459
Open Access | Times Cited: 10
Vivian Hope, Mair Underwood, Kyle Mulrooney, et al.
International Journal of Drug Policy (2021) Vol. 95, pp. 103459-103459
Open Access | Times Cited: 10
‘No one’s going to buy steroids for a home workout’: the impact of the national lockdown on hardcore gym users, anabolic steroid consumption and the image and performance enhancing drugs market
Nick Gibbs
Journal of Contemporary Crime Harm and Ethics (2021) Vol. 1, Iss. 1, pp. 45-62
Open Access | Times Cited: 10
Nick Gibbs
Journal of Contemporary Crime Harm and Ethics (2021) Vol. 1, Iss. 1, pp. 45-62
Open Access | Times Cited: 10
Potential antidepressant effects of a dietary supplement from Huáng qí and its complex in aged senescence-accelerated mouse prone-8 mice
Ming-Yu Chou, Yueching Wong, Shih-Yi Wang, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 3
Ming-Yu Chou, Yueching Wong, Shih-Yi Wang, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 3
Androgen abuse among gay and bisexual men
Scott Griffiths, Dejan Jotanovic, Emma Austen
Current Opinion in Endocrinology Diabetes and Obesity (2021) Vol. 28, Iss. 6, pp. 589-594
Closed Access | Times Cited: 6
Scott Griffiths, Dejan Jotanovic, Emma Austen
Current Opinion in Endocrinology Diabetes and Obesity (2021) Vol. 28, Iss. 6, pp. 589-594
Closed Access | Times Cited: 6
Testosterone and lifespan in males: At the right time and the right level
Lishi Wang, Heliang Yin, Weikuan Gu
Andrologia (2022) Vol. 54, Iss. 11
Open Access | Times Cited: 4
Lishi Wang, Heliang Yin, Weikuan Gu
Andrologia (2022) Vol. 54, Iss. 11
Open Access | Times Cited: 4
How Digital Fitness Forums Shape IPED Access, Use, and Community Harm Reduction Behaviours
Luke A. Turnock, Honor D. Townshend
Research in the sociology of sport (2022), pp. 155-179
Closed Access | Times Cited: 4
Luke A. Turnock, Honor D. Townshend
Research in the sociology of sport (2022), pp. 155-179
Closed Access | Times Cited: 4